VitaNova Life Sciences (VNOV) Receivables - Other (2019 - 2025)
VitaNova Life Sciences (VNOV) reported Receivables - Other of $158802.0 for Q2 2025, down 65.54% on a YoY basis from $460870.0 in Q2 2024, and down 65.54% quarter-over-quarter from $460870.0 in Q2 2024.
VitaNova Life Sciences (VNOV) Receivables - Other (2019 - 2025) Analysis & Trends
VitaNova Life Sciences has reported Receivables - Other for 3 years, with the latest figure at $158802.0 in Q2 2025.
- For the quarter ending Q2 2025, Receivables - Other fell 65.54% year-over-year to $158802.0; the trailing twelve-month figure through Apr 2025 stood at $158802.0 (down 65.54% YoY), and the FY2025 full-year result was $158802.0, down 65.54% from the prior year.
- Receivables - Other for Q2 2025 stood at $158802.0, down from $460870.0 in the prior quarter.
- The five-year high for Receivables - Other was $460870.0 in Q2 2024, with the low at $156000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 158,802.00 |
| Apr 30, 2025 | 158,802.00 |
| Apr 30, 2024 | 460,870.00 |
| Apr 30, 2024 | 460,870.00 |
| Jan 31, 2024 | 156,000.00 |
| Jan 31, 2024 | 156,000.00 |
| Jan 31, 2019 | 36,696.00 |
| Jan 31, 2019 | 36,696.00 |